IP Library › Granted Patent US 8,236,930
Granted Patent B2
US 8,236,930 · App. 13/099,196 · Granted Aug 7, 2012

Binding molecules to the human OX40 receptor

Assignee: Pfizer Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,236,930
App. No.
13/099,196
Granted
Aug 7, 2012
Kind
B2
Abstract

The present disclosure provides isolated binding molecules that bind to the human OX40R, nucleic acid molecules encoding an amino acid sequence of the binding molecules, vectors comprising the nucleic acid molecules, host cells containing the vectors, methods of making the binding molecules, pharmaceutical compositions containing the binding molecules, and methods of using the binding molecules or compositions.

Claims (19)

1. An isolated binding molecule that binds to human OX40R, comprising:

(a) a heavy chain CDR1 comprising an amino acid sequence of SEQ ID NO: 13;

(b) a heavy chain CDR2 comprising an amino acid sequence of SEQ ID NO: 14; and

(c) a heavy chain CDR3 comprising an amino acid sequence of SEQ ID NO: 15.

2. An isolated binding molecule that binds to human OX40R, comprising:

(a) a light chain CDR1 comprising an amino acid sequence of SEQ ID NO: 16;

(b) a light chain CDR2 comprising an amino acid sequence of SEQ ID NO: 17; and

(c) a light chain CDR3 comprising an amino acid sequence of SEQ ID NO: 18.

3. An isolated binding molecule that binds to human OX40R, comprising:

(a) a heavy chain CDR1 comprising an amino acid sequence of SEQ ID NO: 13;

(b) a heavy chain CDR2 comprising an amino acid sequence of SEQ ID NO: 14;

(c) a heavy chain CDR3 comprising an amino acid sequence of SEQ ID NO: 15;

(d) a light chain CDR1 comprising an amino acid sequence of SEQ ID NO: 16;

(e) a light chain CDR2 comprising an amino acid sequence of SEQ ID NO: 17; and

(f) a light chain CDR3 comprising an amino acid sequence of SEQ ID NO: 18.

4. An isolated binding molecule that binds to human OX40R, comprising:

(a) a heavy chain variable region comprising the amino acid sequence of SEQ ID NO: 19; and

(b) a light chain variable region comprising the amino acid sequence of SEQ ID NO: 20.

5. An isolated human monoclonal antibody that binds to human OX40R, which comprises a heavy chain comprising the amino acid sequence of SEQ ID NO: 21 and a light chain comprising the amino acid sequence of SEQ ID NO: 22.

Continuity (3)
Division 12332944 · Dec 11, 2008
Provisional Application 61013947 · Dec 14, 2007
Related Publication 20110206681A1 · Aug 25, 2011